Bernard Ravina is Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR). They have made 7 open-market trades across 1 company since 2017, most recently 2022-02-12.
CIK 0001711276
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYGR | SELL · 10b5-1 | 2018-04-10 | 2018-04-12 | $18.38 | $45K | -10.1% | -1.7% | -8.0% |
| VYGR | SELL | 2018-03-12 | 2018-03-14 | $25.16 | $123K | -12.7% | -18.5% | -8.5% |
| VYGR | SELL · 10b5-1 | 2018-02-12 | 2018-02-13 | $18.24 | $45K | +60.2% | +17.5% | +4.4% |
| VYGR | SELL | 2018-01-10 | 2018-01-12 | $16.40 | $119K | +17.9% | +1.5% | +6.8% |
| VYGR | SELL | 2017-12-11 | 2017-12-13 | $13.63 | $150K | +13.5% | +26.1% | +66.4% |
| VYGR | SELL | 2017-11-10 | 2017-11-13 | $13.26 | $146K | +17.3% | +19.1% | +52.1% |
| VYGR | SELL | 2017-10-10 | 2017-10-12 | $20.33 | $446K | -16.5% | -52.6% | -32.8% |
| VYGR | SELL | 2017-09-05 | 2017-09-06 | $10.00 | $55K | +24.4% | +48.5% | -4.8% |
| VYGR | SELL | 2017-07-20 | 2017-09-13 | $12.87 | $212K | +19.0% | +32.5% | -12.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.